Sep 21, 2021 / 02:00PM GMT
Michael Hencke - Biogen Inc. - Director of IR
Good morning, everyone. Thank you for joining us for our Investor R&D Day. I'm Mike Hencke in Investor Relations.
Before we begin, I would like to point out that we will be making forward-looking statements, which are based on our current expectations and beliefs. These statements are subject to certain risks and uncertainties. I encourage you to consult the risk factors in our SEC filings for additional detail.
We're excited to share with you today the progress we are making in R&D across neuroscience. Today's program will include multiple live presentations followed by a live Q&A session. The slides presented today can be found on the Investor section of our website.
We'll begin with presentations from our Chief Executive Officer, Michel Vounatsos; and Al Sandrock, our Head of R&D. You will then hear from a number of other senior leaders across therapeutic areas. And we will conclude with the Q&A session. We will take a short break at approximately 11:30 a.m. And we aim to conclude today's event at
Biogen Inc Investor Day Transcript
Jan 22, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers